EMGE Emergent Health Corp (PK)

Emergent Health Corp. (Other OTC: EMGE) -- Emergent expects to revolutionize the vitamin business. The company plans to introduce an adjuvant formula that enhances existing vitamin products currently on the market to assist in the production of normal cells. With the addition of Emergent's Vita-Stim Adjuvant™, a trademarked and patented formula, existing vitamin companies will be able to deliver scientifically advanced, revolutionary vitamin products and formulas to United States and worldwide customers. Emergent, licensed under a U.S. patent, is positioned well for this innovative approach.

"The multi-vitamin segment of the supplement market is the largest individual segment. An Industry analyst estimates the market for multi-vitamins is $4 Trillion in the USA. Of over 110 top brands only 11 even supplied 25% of what the body is known to need. Our Vita-Stem Adjuvant™ compound stands to revolutionize the whole vitamin industry, as breakthrough adult stem cell based discoveries are further studied and introduced, providing high potency, scientifically researched regenerative properties to existing vitamin brands. It is predicted that today's vitamin products will eventually become obsolete."

Label description is expected "Contains Value Added Vita-Stim Adjuvant™." If merely 50 to 100 mg. of the adjuvant per formula is used, the market implications are obvious.

Emergent is a multi-specialty biotechnology organization dedicated to the discovery, development, innovation and commercialization of formulas, adjuvants and non-prescription products for mass markets. http://www.emergenthealth.com

This press release contains certain "forward-looking" statements, as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

Emergent Health (PK) (USOTC:EMGE)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Emergent Health (PK) (USOTC:EMGE)
Historical Stock Chart
Von Apr 2024 bis Apr 2025